Biochemical marker of use is a better predictor of outcomes than self-report metrics in a contingency management smoking cessation analog study

American Journal on Addictions

Volumn 23, Issue 1, 2014, Pages 15-20

  Mcpherson, Sterling ^a,b   Packer, Robert R ^a,b   Cameron, Jennifer M ^a,b   Howell, Donelle N ^a,b   Roll, John M ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARBON MONOXIDE; COTININE; BIOLOGICAL MARKER;

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; CARBON MONOXIDE BLOOD LEVEL; CARBON MONOXIDE GAS ANALYZER; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELISA KIT; ENZYME IMMUNOASSAY; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTCOME ASSESSMENT; PREDICTION; RACE; REINFORCEMENT; SALIVA ANALYSIS; SELF REPORT; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; ADOLESCENT; BEHAVIOR THERAPY; BREATH ANALYSIS; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SALIVA; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BEHAVIOR THERAPY; BIOLOGICAL MARKERS; BREATH TESTS; CARBON MONOXIDE; COTININE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SALIVA; SELF REPORT; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84890123181     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.12059.x     Document Type: Article

References (31)

1. United States Department of Health and Human Services (USDHHS). The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services; 1990. DHHS Publication No. (CDC) 90-8416.
2. Peto R, Lopez AD., Mortality from smoking in developed countries: 1950-2000. 2012; http://www.ctsu.ox.ac.uk/deathsfromsmoking/. Accessed January 25, 2012.
3. Peto R, Lopez AD, Boreham J, et al. Mortality from smoking worldwide. Brit Med Bull. 1996; 52: 12-21.
4. Rigotti NA., Treatment of tobacco use and dependence. New Engl J Med. 2002; 346: 506-512.
5. Preston KL, Silverman K, Higgins ST, et al. Cocaine use early in treatment predicts outcome in a behavioral treatment program. J Consult Clin Psychol. 1998; 66: 691-696.
6. Yoon JH, Higgins ST, Bradstreet MP, et al. Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence. Psychopharmacology. 2009; 205: 305-318.
7. Alterman AI, Kampman K, Boardman CR, et al. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug Alcohol Depend. 1997; 46: 79-85.
8. Ehrman RN, Robbins SJ, Cornish JW., Results of a baseline urine test predict levels of cocaine use during treatment. Drug Alcohol Depend. 2001; 62: 1-7.
9. Stitzer ML, Peirce J, Petry NM, et al. Abstinence-based incentives in methadone maintenance: Interaction with intake stimulant test results. Exp Clin Psychopharmacol. 2007; 15: 344-350.
10. Stitzer ML, Petry N, Peirce J, et al. Effectiveness of abstinence-based incentives: Interaction with intake stimulant test results. J Consult Clin Psychol. 2007; 75: 805-811.
11. Stitzer ML, Iguchi MY, Felch LJ., Contingent take-home incentive-Effects on drug-use of methadone-maintenance patients. J Consult Clin Psychol. 1992; 60: 927-934.
12. Tzilos GK, Rhodes GL, Ledgerwood DM, et al. Predicting cocaine group treatment outcome in cocaine-abusing methadone patients. Exp Clin Psychopharmacol. 2009; 17: 320-325.
13. Higgins ST, Stoller K, Heil SH, eds. Contingency Management in Substance Abuse Treatment. New York, NY: Guilford Press; 2008.
14. Norregaard J, Tonnesen P, Petersen L., Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med. 1993; 22: 261-271.
15. Paoletti P, Fornai E, Maggiorelli F, et al. Importance of baseline cotinine plasma values in smoking cessation: Results from a double-blind study with nicotine patch. Eur Respir J. 1996; 9: 643-651.
16. Fagerstrom KO., Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978; 3: 235-241.
17. Gorber SC, Schofield-Hurwitz S, Hardt J, et al. The accuracy of self-reported smoking: A systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009; 11: 12-24.
18. Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: A review and meta-analysis. Am J Public Health. 1994; 84: 1086-1093.
19. Packer RR, Howell DN, McPherson S, et al. Investigating reinforcer magnitude and reinforcer delay: A contingency management analog study. Exp Clin Psychopharmacol. 2012; 20: 287-292.
20. Roll JM, Higgins ST, Badger GJ., An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J Appl Behav Anal. 1996; 29: 495-505.
21. Cropsey KL, Eldridge GD, Weaver MF, et al. Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine Tob Res. 2006; 8: 653-659.
22. Javors MA, Hatch JP, Lamb RJ., Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction. 2005; 100: 159-167.
23. Dallery J, Meredith S, Glenn IM., A deposit contract method to deliver abstinence reinforcement for cigarette smoking. J Appl Behav Anal. 2008; 41: 609-615.
24. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86: 1119-1127.
25. Corby EA, Roll JM, Ledgerwood DM, et al. Contingency management interventions for treating the substance abuse of adolescents: A feasibility study. Exp Clin Psychopharmacol. 2000; 8: 371-376.
26. Roll JM, Higgins ST., A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug Alcohol Depend. 2000; 58: 103-109.
27. Roll JM, Higgins ST, Steingard S, et al. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: A feasibility study. Exp Clin Psychopharmacol. 1998; 6: 157-161.
28. Roll JM, Howard JT., The relative contribution of economic valence to contingency management efficacy: A pilot study. J Appl Behav Anal. 2008; 41: 629-633.
29. Cooke F, Bullen C, Whittaker R, et al. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res. 2008; 10: 607-612.
30. Montalto NJ, Wells WO., Validation of self-reported smoking status using saliva cotinine: A rapid semiquantitative dipstick method. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1858-1862.
31. Podsakoff PM, MacKenzie SB, Lee JY, et al. Common method biases in behavioral research: A critical review of the literature and recommended remedies. J Appl Psychol. 2003; 88: 879-903.